Arnaud Jacquel

Arnaud Jacquel

UNVERIFIED PROFILE

Are you Arnaud Jacquel?   Register this Author

Register author
Arnaud Jacquel

Arnaud Jacquel

Publications by authors named "Arnaud Jacquel"

Are you Arnaud Jacquel?   Register this Author

54Publications

1557Reads

35Profile Views

Chaperone-Mediated Autophagy and Its Emerging Role in Hematological Malignancies.

Cells 2019 Oct 16;8(10). Epub 2019 Oct 16.

Mediterranean Center for Molecular Medicine ,Université Nice Côte d'Azur, C3M/Inserm1065, 06100 Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8101260DOI Listing
October 2019

Rab4b Deficiency in T Cells Promotes Adipose Treg/Th17 Imbalance, Adipose Tissue Dysfunction, and Insulin Resistance.

Cell Rep 2018 12;25(12):3329-3341.e5

INSERM UMR1065, Mediterranean Center of Molecular Medicine C3M, Team "Cellular and Molecular Physiopathology of Obesity and Diabetes," Nice, France; Université Côte d'Azur, Nice, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.11.083DOI Listing
December 2018

Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation.

Int J Mol Sci 2018 Sep 30;19(10). Epub 2018 Sep 30.

Université Côte d'Azur, C3M Inserm U1065, 06204 Nice, France.

View Article

Download full-text PDF

Source
http://www.mdpi.com/1422-0067/19/10/2991
Publisher Site
http://dx.doi.org/10.3390/ijms19102991DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213055PMC
September 2018

Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia.

Oncotarget 2018 Jan 15;9(3):3417-3431. Epub 2017 Dec 15.

Department of Molecular Medicine and Medical Biotechnology, University of Naples, Federico II, Naples 80131, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790473PMC
January 2018

[Autophagy, a key player in leukemogenesis and a therapeutic target in hematopoietic malignancies].

Med Sci (Paris) 2017 Mar 3;33(3):226-229. Epub 2017 Apr 3.

Inserm U1065 (C3M), Université Nice Côte d'Azur, Hôpital de l'Archet, bâtiment Archimed, 151 route de St-Antoine de Ginèstière, 06204 Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20173303007DOI Listing
March 2017

DNA Damage and the Activation of the p53 Pathway Mediate Alterations in Metabolic and Secretory Functions of Adipocytes.

Diabetes 2016 10 7;65(10):3062-74. Epub 2016 Jul 7.

INSERM, UMR 1065, C3M, Team 7 Molecular and Cellular Physiopathology of Obesity and Diabetes, Nice, France Université Côte d'Azur, C3M, Nice, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/db16-0014DOI Listing
October 2016

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

Sci Adv 2015 Sep 18;1(8):e1500221. Epub 2015 Sep 18.

Institut Cochin, Département Développement, Reproduction, Cancer, CNRS, UMR 8104, INSERM U1016, Paris 75014, France. ; Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris 75005, France. ; Equipe Labellisée, Ligue Nationale Contre le Cancer (LNCC), Paris 75013, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/sciadv.1500221DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643770PMC
September 2015

CD271 is an imperfect marker for melanoma initiating cells.

Oncotarget 2014 Jul;5(14):5272-83

INSERM U1065, Equipe 1, Biologie et pathologies des mélanocytes: de la pigmentation cutanée au mélanome, Equipe labellisée Ligue 2013, Centre Méditerranéen de Médecine Moléculaire, Nice, France; Université de Nice Sophia-Antipolis, UFR Médecine, Nice, France; CHU Nice, Service de Dermatologie, Nice, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170612PMC
http://dx.doi.org/10.18632/oncotarget.1967DOI Listing
July 2014

Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines.

Oncotarget 2014 Jun;5(12):4384-91

INSERM U1065, Mediterranean Center for Molecular Medicine (C3M), Nice, France; University of Nice, Nice, France; Department of Clinical hematology and Transplantation, CHU of Nice, Nice, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147331PMC
http://dx.doi.org/10.18632/oncotarget.2024DOI Listing
June 2014

cIAPs and XIAP reduce RIPKs to silence.

Blood 2014 Apr;123(16):2445-6

UNIVERSITY OF NICE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-02-555771DOI Listing
April 2014

How recent advances in high-risk myelodysplastic syndrome physiopathology may impact future treatments.

Curr Pharm Des 2013 ;19(30):5362-73

INSERM U1065, Centre Mediterraneen de Médecine Moléculaire (C3M), Team Cell Death, Differentiation, Inflammation and Cancer, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/13816128113199990334DOI Listing
March 2014

Proper macrophagic differentiation requires both autophagy and caspase activation.

Autophagy 2012 Jul 1;8(7):1141-3. Epub 2012 Jul 1.

INSERM U1065, Centre Méditerranéen de Médecine Moléculaire, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/auto.20367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429551PMC
July 2012

Mechanism of action of the multikinase inhibitor Foretinib.

Cell Cycle 2011 Dec 1;10(23):4138-48. Epub 2011 Dec 1.

INSERM U895, Centre Meditérranéen de Médecine Moléculaire, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.10.23.18323DOI Listing
December 2011

Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells.

Oncotarget 2011 Nov;2(11):874-85

INSERM U895, Centre Méditerranéen de Médecine Moléculaire, Team Cell Death, Differentiation, Inflammation and Cancer, Nice, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259992PMC
http://dx.doi.org/10.18632/oncotarget.360DOI Listing
November 2011

Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line.

Autophagy 2009 Nov 24;5(8):1092-8. Epub 2009 Nov 24.

Inserm U895, Team 2: Cell Death Differentiation and Cancer, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/auto.5.8.9889DOI Listing
November 2009

Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells.

Cancer Res 2009 Apr 24;69(7):3013-20. Epub 2009 Mar 24.

Institut National de la Sante et de la Recherche Medicale, U895, équipe 3 Avenir, Faculté de Médecine, Nice, France.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-08-2731DOI Listing
April 2009

Various functions of caspases in hematopoiesis.

Front Biosci (Landmark Ed) 2009 Jan 1;14:2358-71. Epub 2009 Jan 1.

Inserm, UMR 866, Dijon, F-21079 France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2741/3383DOI Listing
January 2009

Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis.

Oncogene 2004 Oct;23(47):7863-73

INSERM U526, Physiopathologie de la Survie et de la Mort Cellulaires et Infections Virales, Equipe Labellisée par la Ligue Nationale contre le Cancer, IFR50, Faculté de Médecine, Avenue de Valombrose, 06107 Nice Cedex 2, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208069DOI Listing
October 2004

Imatinib mesylate (STI571) decreases the vascular endothelial growth factor plasma concentration in patients with chronic myeloid leukemia.

Blood 2004 Jul 19;104(2):495-501. Epub 2004 Feb 19.

Service d'Hématologie, Hôpital Archet 1, 151, Route de Saint Antoine de Ginestière, BP 3079, 06202 Nice Cedex 2, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-08-2695DOI Listing
July 2004

Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.

FASEB J 2003 Nov;17(14):2160-2

INSERM U526, Physiopathologie de la Survie et de la Mort Cellulaires et Infections Virales Equipe Labellisée par la Ligue Nationale contre le Cancer, Nice, France.

View Article

Download full-text PDF

Source
http://www.fasebj.org/lookup/doi/10.1096/fj.03-0322
Publisher Site
http://dx.doi.org/10.1096/fj.03-0322DOI Listing
November 2003

Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function.

Oncogene 2003 Oct;22(43):6785-93

INSERM Unit 526, LNC Label, Faculté de Médecine, 28 Avenue de Valombrose, 06107 Nice Cedex 02, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206792DOI Listing
October 2003

The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis.

FASEB J 2003 Apr 5;17(6):711-3. Epub 2003 Feb 5.

INSERM U526 Activation des Cellules Hematopoietiques, Physiopathologie de la Survie et de la Mort Cellulaires et Infections Virales, Equipe Labellisée Ligue Nationale contre le Cancer, IFR50, Faculté de Médecine, 06107 Nice-Cédex 2, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.02-0716fjeDOI Listing
April 2003